🟠 Moderate Evidence
A controlled clinical trial has demonstrated that supplementing older adults with glycine and N-acetylcysteine (NAC) can restore glutathione levels toward youthful ranges and improve multiple markers of aging-related decline, including mitochondrial function, oxidative stress, insulin resistance, and muscle strength. The study suggests that addressing substrate deficiencies in glutathione synthesis may correct multiple biological hallmarks of aging simultaneously, rather than targeting single pathways with conventional antioxidants.
Key takeaways
- Aging is associated with declining glutathione, mitochondrial dysfunction, and chronic inflammation — three interconnected biological processes
- Supplementing glycine and NAC together removes both rate-limiting bottlenecks in glutathione synthesis, restoring levels toward those observed in younger adults
- Improvements extended beyond glutathione to mitochondrial fuel utilization, oxidative stress markers, insulin sensitivity, and muscle strength
- The protocol used approximately 100 mg/kg/day of each amino acid, divided into multiple daily doses
Study at a Glance
| Study type | Controlled clinical trial |
| Intervention | Glycine + N-acetylcysteine (NAC) |
| Population | Older adults with age-related metabolic decline |
| Primary endpoints | Glutathione levels, mitochondrial function, oxidative stress, insulin resistance, inflammation, muscle strength |
| Duration | Multiple weeks |
Biomarkers improve toward youthful ranges after glycine and NAC supplementation
Change in aging-related markers in older adults following substrate-repletion therapy
Source: Clinical trial data | Georgian Medical Journal News
The mechanistic rationale: removing bottlenecks in glutathione synthesis
Glutathione, a tripeptide composed of glutamate, cysteine, and glycine, is the cell’s primary antioxidant and redox buffer. According to the trial, aging adults presented with depleted glutathione stores, impaired mitochondrial fuel utilization, and elevated oxidative stress — suggesting that glutathione depletion is a central feature of aging-related metabolic dysfunction. The study found that both cysteine (supplied by NAC) and glycine represent rate-limiting substrates in glutathione synthesis, meaning that providing only one would leave the pathway constrained. By supplying both simultaneously, the researchers removed both biochemical bottlenecks, allowing endogenous glutathione production to recover.
This approach differs fundamentally from conventional antioxidant supplementation (vitamins C and E, for example), which provides finished antioxidant molecules but does not address the underlying depletion of the cell’s own glutathione-synthesis machinery. The trial suggests that correcting substrate availability — rather than compensating with exogenous antioxidants — may restore core aging-related defects more comprehensively.
Multiple biomarkers shift toward youthful profiles
The trial’s most significant finding was the coordinated improvement across multiple aging-related parameters. According to the study results, supplementation with glycine and NAC did not merely produce modest reductions in oxidative stress markers; instead, several abnormal values moved substantially toward those observed in young adults. Mitochondrial function, as assessed by fuel utilization efficiency, improved markedly. Insulin resistance, a hallmark of age-related metabolic decline and cardiovascular disease risk, was reduced. Inflammatory biomarkers, which typically rise chronically with age, showed measurable decreases. Muscle strength, a functional outcome directly affecting quality of life and mortality risk in older populations, also improved.
This multi-system response suggests that glutathione depletion may be a convergent mechanism linking energy metabolism, redox balance, glucose homeostasis, inflammation, and muscular function in aging — and that correcting it centrally may address multiple downstream pathologies at once. See our Clinical Updates section for emerging therapies targeting aging mechanisms.
Supplementing glycine and NAC restored glutathione levels toward youthful ranges and simultaneously improved mitochondrial function, oxidative stress markers, insulin resistance, inflammation, and muscle strength in aging adults — suggesting substrate-repletion may address multiple aging-related defects at once.
Clinical trial findings on amino acid supplementation and glutathione restoration
Protocol, limitations, and next steps
The trial protocol employed approximately 100 mg/kg/day of glycine and 100 mg/kg/day of NAC, divided into multiple daily doses and administered over several weeks. This substrate-repletion dosing is substantially higher than typical antioxidant supplement doses and reflects the goal of actually restoring tissue glutathione stores rather than providing pharmacological doses of finished antioxidants. The study was a controlled clinical trial with a clear mechanistic hypothesis; however, readers should note that this summary reports trial findings without access to detailed peer-reviewed publication data, statistical analyses, or control group specifications. Replication in larger randomized controlled trials, assessment of long-term safety and tolerability, and evaluation of clinically relevant endpoints (mortality, hospitalization, functional independence) would strengthen the evidence base. Furthermore, this work addresses biology; it is not medical advice, and older adults considering such supplementation should consult their physicians, particularly if taking other medications or managing chronic conditions.
Explore more recent aging research and clinical trials in our New Studies archive. The intersection of mitochondrial function and aging biology continues to yield novel therapeutic targets, and substrate-repletion strategies represent a mechanistically distinct approach from conventional pharmaceutical and nutraceutical interventions.
What this means
Frequently asked questions
Why is glutathione depletion a hallmark of aging?
Glutathione serves as the cell’s primary antioxidant and redox buffer, protecting against oxidative damage and maintaining mitochondrial function. With age, glutathione synthesis declines — partly because glycine and cysteine become relatively depleted — and this depletion is associated with increased oxidative stress, mitochondrial dysfunction, inflammation, and age-related disease. Restoring glutathione availability may reverse this cycle.
Why use both glycine and NAC together, rather than just one?
Glutathione synthesis requires three amino acids: glutamate, cysteine, and glycine. In aging, both cysteine and glycine become rate-limiting, meaning that providing only one would leave the pathway bottlenecked. By supplying both simultaneously, the cell can maximize glutathione production. NAC is converted to cysteine; glycine is provided directly.
Is this treatment proven to extend lifespan or prevent age-related disease in humans?
This trial demonstrated improvements in biomarkers associated with aging and disease risk (mitochondrial function, insulin resistance, inflammation, muscle strength) in older adults. However, longer-term studies assessing clinical outcomes such as mortality, cardiovascular events, cognitive decline, and functional independence would be needed to establish whether these biomarker improvements translate to meaningful health benefits or extended healthspan.
The findings presented in this trial represent a mechanistically grounded approach to aging biology — one that targets substrate availability rather than symptom management. As the field of gerontology shifts toward addressing fundamental aging processes, substrate-repletion strategies like glycine and NAC supplementation may become part of a broader toolbox for promoting healthy aging and extending functional independence in older populations.
Source: Clinical trial examining glycine and N-acetylcysteine supplementation in aging adults | Georgian Medical Journal News
Was this article helpful?
Related Coverage




Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.






